JD Health International (FRA:8ZN) EPS (Basic): €0.22 (TTM As of Dec. 2025)


FRA:8ZN JD Health International Inc FRA:8ZN
90 GF Score
Price €3.72
GF Value €6.38
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is JD Health International EPS (Basic)?

JD Health International FRA:8ZN +1.61% 90 EPS (Basic) is €0.22 as of Dec. 2025. GuruFocus rates FRA:8ZN with a GF Score™ of 90/100 and a GF Value™ of €6.38 (Significantly Undervalued). The stock has 1 warning sign investors should review.

JD Health International's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was €0.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.22.

JD Health International's EPS (Diluted) for the six months ended in Dec. 2025 was €0.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.20.

JD Health International's EPS without NRI for the six months ended in Dec. 2025 was €0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.21.

During the past 12 months, JD Health International's average EPS without NRIGrowth Rate was 26.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 128.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, JD Health International's highest 3-Year average EPS without NRI Growth Rate was 128.10% per year. The lowest was 128.10% per year. And the median was 128.10% per year.

JD Health International  (FRA:8ZN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

JD Health International EPS (Basic) Related Terms

JD Health International EPS (Basic) Historical Data

* Premium members only.

The historical data trend for JD Health International's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International EPS (Basic) Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -0.05 0.02 0.09 0.17 0.22

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.08 0.09 0.10 0.12
FRA:8ZN
90GF Score
JD Health International Inc FRA:8ZN
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

JD Health International's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(651.777-0)/3163.483
=0.21

JD Health International's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(336.954-0)/3166.614
=0.11

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.22 mean?
JD Health International (FRA:8ZN) has a EPS (Basic) of €0.22 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on JD Health International and its competitors.
Is JD Health International's EPS (Basic) too high?
JD Health International's current EPS (Basic) is €0.22. Overall, JD Health International has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JD Health International's EPS (Basic) compare to competitors?
JD Health International's EPS (Basic) of €0.22 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Healthcare Providers & Services company?
A good EPS (Basic) depends on the Healthcare Providers & Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on JD Health International and its competitors. JD Health International's current EPS (Basic) is €0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
Based on GuruFocus' analysis, JD Health International (FRA:8ZN) is currently considered Significantly Undervalued. The stock's GF Value™ is €6.38, compared to a current price of €3.72 — trading 41.7% below its estimated fair value. The current EPS (Basic) is €0.22. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For JD Health International (FRA:8ZN), the current EPS (Basic) is €0.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JD Health International (FRA:8ZN) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of €3.72 is trading 41.7% below its estimated GF Value™ of €6.38. GuruFocus considers JD Health International to be Significantly Undervalued.

Key valuation signals for FRA:8ZN:

  • EPS (Basic): €0.22
  • GF Value™: €6.38 vs. price of €3.72 (41.7% below fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the FRA:8ZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score

Get the complete analysis for FRA:8ZN

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€6.38
GF Value